GB9621367D0 - Chiral peptide nucleic acids - Google Patents

Chiral peptide nucleic acids

Info

Publication number
GB9621367D0
GB9621367D0 GBGB9621367.3A GB9621367A GB9621367D0 GB 9621367 D0 GB9621367 D0 GB 9621367D0 GB 9621367 A GB9621367 A GB 9621367A GB 9621367 D0 GB9621367 D0 GB 9621367D0
Authority
GB
United Kingdom
Prior art keywords
nucleic acids
peptide nucleic
chiral peptide
chiral
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9621367.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB9621367.3A priority Critical patent/GB9621367D0/en
Publication of GB9621367D0 publication Critical patent/GB9621367D0/en
Priority to PCT/GB1997/002820 priority patent/WO1998016550A1/en
Priority to US09/284,179 priority patent/US6403763B1/en
Priority to EP97945009A priority patent/EP0956297A1/en
Priority to JP10518106A priority patent/JP2001502673A/ja
Priority to US09/932,862 priority patent/US6713603B2/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Saccharide Compounds (AREA)
GBGB9621367.3A 1996-10-14 1996-10-14 Chiral peptide nucleic acids Pending GB9621367D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9621367.3A GB9621367D0 (en) 1996-10-14 1996-10-14 Chiral peptide nucleic acids
PCT/GB1997/002820 WO1998016550A1 (en) 1996-10-14 1997-10-13 Chiral peptide nucleic acids
US09/284,179 US6403763B1 (en) 1996-10-14 1997-10-13 Chiral peptide nucleic acids
EP97945009A EP0956297A1 (en) 1996-10-14 1997-10-13 Chiral peptide nucleic acids
JP10518106A JP2001502673A (ja) 1996-10-14 1997-10-13 キラルペプチド核酸
US09/932,862 US6713603B2 (en) 1996-10-14 2001-08-17 Chiral peptide nucleic acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9621367.3A GB9621367D0 (en) 1996-10-14 1996-10-14 Chiral peptide nucleic acids

Publications (1)

Publication Number Publication Date
GB9621367D0 true GB9621367D0 (en) 1996-12-04

Family

ID=10801375

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9621367.3A Pending GB9621367D0 (en) 1996-10-14 1996-10-14 Chiral peptide nucleic acids

Country Status (5)

Country Link
US (2) US6403763B1 (enExample)
EP (1) EP0956297A1 (enExample)
JP (1) JP2001502673A (enExample)
GB (1) GB9621367D0 (enExample)
WO (1) WO1998016550A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US9096636B2 (en) 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
GB9621367D0 (en) * 1996-10-14 1996-12-04 Isis Innovation Chiral peptide nucleic acids
US6326479B1 (en) * 1998-01-27 2001-12-04 Boston Probes, Inc. Synthetic polymers and methods, kits or compositions for modulating the solubility of same
JP2002537102A (ja) 1999-02-26 2002-11-05 カイロン コーポレイション 吸着された高分子および微粒子を有するミクロエマルジョン
JP2004514427A (ja) * 2000-11-24 2004-05-20 パンセコ・アクティーゼルスカブ Ｐｎａ類似物
AU2002216946A1 (en) * 2001-01-05 2002-07-16 Pantheco A/S Modified pna molecules
US6716961B2 (en) * 2001-10-30 2004-04-06 Isis Innovation Limited Chiral peptide nucleic acids with a N-aminoethyl-d-proline backbone
EP1513871B1 (en) * 2002-02-04 2008-10-29 Isis Innovation Limited Pyrrolidinyl peptide nucleic acids
EP1560840B1 (en) * 2002-11-05 2015-05-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
EA009302B1 (ru) * 2003-05-20 2007-12-28 Инвестиген, Инк. Система обнаружения полинуклеотидов
US7790691B2 (en) 2003-06-20 2010-09-07 Isis Pharmaceuticals, Inc. Double stranded compositions comprising a 3′-endo modified strand for use in gene modulation
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
US8021839B2 (en) * 2006-02-24 2011-09-20 Investigen, Inc. Methods and compositions for detecting polynucleotides
US20080096193A1 (en) * 2006-10-24 2008-04-24 Charles Robert Bupp Methods and compositions for detecting polynucleotides
EP2099816A1 (en) * 2006-12-04 2009-09-16 Luminex Corporation Oxocarbonamide peptide nucleic acids and methods of using same
WO2008103702A2 (en) * 2007-02-23 2008-08-28 Investigen, Inc. Methods and compositions for rapid light-activated isolation and detection of analytes
US7964355B2 (en) * 2009-02-17 2011-06-21 Investigen, Inc. Assays based on detection of photobleaching reaction products from dye catalytic complex
US8785121B2 (en) 2010-07-08 2014-07-22 Bonac Corporation Single-stranded nucleic acid molecule for controlling gene expression
US8691782B2 (en) 2010-08-03 2014-04-08 Bonac Corporation Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
PT2674494E (pt) * 2010-08-03 2015-02-27 Bonac Corp Molécula de arn em cadeia simples com esqueleto licíclico contendo azoto
US9663784B2 (en) 2012-05-26 2017-05-30 Bonac Corporation Single-stranded nucleic acid molecule for regulating expression of gene having delivering function
EP3088524A4 (en) 2013-12-26 2017-08-09 Tokyo Medical University Artificial mimic mirna for controlling gene expression, and use of same
KR102357337B1 (ko) 2013-12-27 2022-01-28 가부시키가이샤 보낙 유전자 발현 제어를 위한 인공 매치형 miRNA 및 그 용도
SG11201705223XA (en) 2014-12-27 2017-07-28 Bonac Corp NATURALLY OCCURING miRNA FOR CONTROLLING GENE EXPRESSION, AND USE OF SAME
WO2016158809A1 (ja) 2015-03-27 2016-10-06 株式会社ボナック デリバリー機能と遺伝子発現制御能を有する一本鎖核酸分子

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA832762B (en) 1982-04-30 1983-12-28 Squibb & Sons Inc Substituted 4-phenoxy prolines
US4501901A (en) * 1983-09-19 1985-02-26 E. R. Squibb & Sons, Inc. Method for making substituted prolines
US5401901A (en) 1991-09-19 1995-03-28 W. L. Gore & Associates, Inc. Weather-resistant electromagnetic interference shielding for electronic equipment enclosures
DE4331011A1 (de) 1993-09-13 1995-03-16 Bayer Ag Nukleinsäuren-bindende Oligomere mit C-Verzweigung für Therapie und Diagnostik
DE4331012A1 (de) * 1993-09-13 1995-03-16 Bayer Ag Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik
GB9621367D0 (en) * 1996-10-14 1996-12-04 Isis Innovation Chiral peptide nucleic acids

Also Published As

Publication number Publication date
US6403763B1 (en) 2002-06-11
JP2001502673A (ja) 2001-02-27
EP0956297A1 (en) 1999-11-17
US6713603B2 (en) 2004-03-30
US20020072586A1 (en) 2002-06-13
WO1998016550A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
GB9621367D0 (en) Chiral peptide nucleic acids
ZA943730B (en) Deoxyribonucleic acids
HU9801045D0 (en) Substituted diamino-carboxylic acids
IL197834A0 (en) Polypeptides and nucleic acids encoding the same
PT1490386E (pt) Novos polipéptidos e ácidos nucleicos que os codificam
EP0990149A4 (en) Nucleic Acid SENSOR
AU6890598A (en) Chiral peptide nucleic acids and methods for preparing same
IL120339A0 (en) Improved DNA assembly method
SI0964856T1 (en) Bicyclic amino acids
GB9408717D0 (en) DNA sequences
IL133948A0 (en) Characterising nucleic acids
AU6667998A (en) Nucleic acids encoding caspase-8h and caspase-8i
ZA9710338B (en) Proteins
PL332553A1 (en) 3-alkooxyisooxazol-4-yl-substituted 2-aminocarboxylic acids
HUP9904186A3 (en) Chiral ferrocenyls
ZA98642B (en) Immune-modulation with amino acids
GB9526218D0 (en) DNA Sequences
ZA975330B (en) Process for the preparation of chiral keto-heterocycles of basic amino acids.
AU6567398A (en) Chiral separations of amino acids
GB9322723D0 (en) Determining nucleic acids
GB9420010D0 (en) Nucleic acids
GB9812674D0 (en) Nucleic acids
ZA988460B (en) Polypeptides and nucleic acids encoding the same
CZ135099A3 (cs) Nalfa-2-(4-Nitrofenylsulfonyl)ethoxykarbonylované aminokyseliny
GB9408064D0 (en) Nucleic acids